Tenax Therapeutics: Near-Term Phase 2 Results Expected to Drive Stock

Mar. 19, 2019
Exclusive interview with Tenax Therapeutics (NASDAQ: TENX) CEO, Anthony DiTonno. TENX is a specialty pharmaceutical company focused on identifying and ...

 Read More

Bloomberg TV Show

CEO Interviews

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market